Tenet Healthcare (NYSE:THC) Hits New 12-Month High – Here’s Why

Tenet Healthcare Corporation (NYSE:THC)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $262.70 and last traded at $262.7870, with a volume of 508079 shares changing hands. The stock had previously closed at $253.33.

Analysts Set New Price Targets

Several analysts have recently weighed in on THC shares. KeyCorp decreased their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Monday, July 27th. UBS Group boosted their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Robert W. Baird raised their price objective on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday, July 28th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $271.00.

Tenet Healthcare Stock Up 2.4%

The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a 50 day simple moving average of $198.44 and a 200-day simple moving average of $200.96. The stock has a market capitalization of $21.16 billion, a price-to-earnings ratio of 10.13, a price-to-earnings-growth ratio of 1.00 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the prior year, the firm earned $4.02 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, sell-side analysts forecast that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.

Insider Buying and Selling

In other Tenet Healthcare news, EVP Paola M. Arbour sold 10,878 shares of Tenet Healthcare stock in a transaction on Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the completion of the transaction, the executive vice president owned 18,413 shares in the company, valued at approximately $4,490,930.70. The trade was a 37.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 33,353 shares of company stock valued at $7,683,517 in the last ninety days. 0.97% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. NewEdge Advisors LLC grew its stake in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after buying an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new position in Tenet Healthcare in the 2nd quarter valued at $290,000. Quantbot Technologies LP acquired a new stake in shares of Tenet Healthcare in the 2nd quarter valued at $65,000. Finally, Amundi raised its position in shares of Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after acquiring an additional 26,383 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.